Statement Of Cash Flows [Abstract]

Sopharma AD - Filing #6022427

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Income taxes paid, classified as operating activities
7,937,000 BGN
7,947,000 BGN
Income taxes refund, classified as operating activities
43,000 BGN
78,000 BGN
Cash flows from (used in) investing activities [abstract]
Purchase of interests in associates
20,800,000 BGN
- BGN
Proceeds from sales of interests in associates
213,000 BGN
1,000 BGN
Cash advances and loans made to related parties
8,010,000 BGN
4,532,000 BGN
Cash receipts from repayment of advances and loans made to related parties
10,795,000 BGN
37,151,000 BGN
Purchase of investment property
- BGN
429,000 BGN
Proceeds from sales of investment property
1,952,000 BGN
- BGN
Cash flows from (used in) financing activities [abstract]
Proceeds from sale or issue of treasury shares
- BGN
805,000 BGN
Proceeds from non-current borrowings
16,834,000 BGN
13,576,000 BGN
Repayments of non-current borrowings
19,405,000 BGN
20,241,000 BGN
Proceeds from current borrowings
19,554,000 BGN
14,407,000 BGN
Repayments of current borrowings
27,145,000 BGN
35,683,000 BGN
Proceeds from contributions of non-controlling interests
- BGN
38,000 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.